EWM
ABBV icon

EPG Wealth Management’s AbbVie ABBV Stock Holding History

EPG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Sell
2,458
-8
-0.3% -$1.72K 0.15% 133
2026
Q1 		$536K Sell
2,466
-100
-4% -$22.2K 0.15% 141
2025
Q4 		$586K Buy
2,566
+182
+8% +$41.5K 0.16% 135
2025
Q3 		$552K Sell
2,384
-2
-0.1% -$407 0.15% 138
2025
Q2 		$443K Sell
2,386
-2,439
-51% -$453K 0.13% 147
2025
Q1 		$1.01M Buy
4,825
+23
+0.5% +$4.47K 0.28% 104
2024
Q4 		$853K Sell
4,802
-1,193
-20% -$219K 0.22% 120
2024
Q3 		$1.18M Buy
+5,995
New +$1.12M 0.3% 94
2024
Q2 		– Sell
-7,225
Closed -$1.2M – 86
2024
Q1 		$1.32M Sell
7,225
-32
-0.4% -$5.51K 0.32% 85
2023
Q4 		$1.26M Sell
7,257
-73
-1% -$10.6K 0.33% 84
2023
Q3 		$1.09M Buy
7,330
+197
+3% +$28.9K 0.33% 80
2023
Q2 		$961K Sell
7,133
-139
-2% -$20.4K 0.28% 90
2023
Q1 		$1.16M Sell
7,272
-2,172
-23% -$332K 0.37% 74
2022
Q4 		$1.53M Buy
9,444
+177
+2% +$27.1K 0.58% 34
2022
Q3 		$1.24M Buy
9,267
+572
+7% +$82.1K 0.51% 42
2022
Q2 		$1.33M Buy
8,695
+107
+1% +$16.4K 0.57% 42
2022
Q1 		$1.39M Buy
8,588
+597
+7% +$86.7K 0.48% 49
2021
Q4 		$1.08M Buy
7,991
+573
+8% +$67.7K 0.38% 56
2021
Q3 		$800K Buy
7,418
+1,010
+16% +$115K 0.32% 68
2021
Q2 		$722K Buy
6,408
+2,308
+56% +$260K 0.31% 80
2021
Q1 		$444K Buy
4,100
+36
+0.9% +$3.85K 0.22% 105
2020
Q4 		$435K Buy
4,064
+29
+0.7% +$2.79K 0.26% 89
2020
Q3 		$353K Buy
4,035
+116
+3% +$10.9K 0.26% 89
2020
Q2 		$385K Buy
3,919
+605
+18% +$53.3K 0.27% 88
2020
Q1 		$253K Buy
3,314
+2,902
+704% +$247K 0.19% 99
2019
Q4 		$37K Buy
+412
New +$34.2K 0.03% 267

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EPG Wealth Management's ABBV Position: Q2 2026 in Review

EPG Wealth Management reduced its AbbVie (ABBV) stake by 0.32% in Q2 2026, selling an estimated $1.72K and leaving 2,458 shares worth $618K. The position accounts for 0.15% of the portfolio, ranked #133.

EPG Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.53M in Q4 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EPG Wealth Management held 2,458 shares of AbbVie worth $618K as of Q2 2026.
  • EPG Wealth Management sold 8 AbbVie shares in Q2 2026, an estimated $1.72K.
  • AbbVie made up 0.15% of EPG Wealth Management's portfolio in Q2 2026, its #133 holding.
  • EPG Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • EPG Wealth Management's AbbVie position peaked at $1.53M in Q4 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.